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Over the past four and a half years, ﬁfteen issues of PPAR
Research have been published and an additional ﬁve are
currently in various phases of production. Collectively,
these issues have covered a large array of physiological
functions of PPARs in health and disease, including their
functions in diverse cell and tissue types, their roles in a
host of clinical conditions, and their rich pharmaceutical
potential.Yet,onecrucialoverarchingselectionseemstohave
escaped attention amid this exciting variety—the fundamen-
tal molecular mechanisms that underlie PPAR action. PPARs
are ﬁrst and foremost transcription factors that execute
intricate regulation of gene networks, and are in turn subject
to complex ﬁne-tuning and control. Inevitably, thorough
understanding of their cellular and organismal functions
andfullcapitalizationontheirpharmaceuticalpowerrequire
detailed understanding of these molecular underpinnings.
While the list of potential subplots is far too long to ﬁt
into a single issue, the current issue has begun to ﬁll this
coverage gap. Three review articles and one research
manuscript tackle the subject of PPAR target genes. First
is a comprehensive review of PPARα target genes by
Rakhshandehroo et al. Although the primary focus of their
review is hepatic targets, many of the discussed features are
applicable to the physiology of PPARα in other tissues. Next,
Bugge and Mandrup review two complementary aspects
of PPARγ-regulated genes. The ﬁrst concerns the role of
the N-terminal ligand-independent activation domain, also
known as the A/B or AF-1 domain, in determining PPAR
subtype speciﬁcity and in modulating target activation
in adipocytes. The second focuses on recent insights into
genomewide PPARγ actions in adipocytes and macrophages
gained from chromatin immunoprecipitation studies. In the
third review, Costa et al. discuss population-wide sequence
variations of PPARγ and their potential impact on target
gene expression, and review the application of massive
parallel sequencing for the identiﬁcation of PPARγ cistromes
(the collection of genomic sequences bound by PPARγ)
and transcriptomes. In the second section of this issue, the
research article by Le Bouter et al. analyzes gene expression
changes in adipose tissue, liver, and muscle of leptin receptor
deﬁcient diabetic obese mice treated with the PPARγ agonist
and insulin sensitizer rosiglitazone, in order to establish the
molecular basis of its therapeutic physiological eﬀects.
Two papers by Viswakarma et al. and Pyper et al., one
a review and the other a research manuscript, concern
transcription cofactors of PPARs. Their thorough review
summarizes no less than twelve types of PPAR coactivators,
which, ironically, do not account for the fullest gamut of
known PPAR coactivators. Nothing is better to illustrate
the complexity of this ever-growing subplot than this
group’s accompanying research article, which describes the
identiﬁcation and initial characterization of yet a new PPAR
coactivator, a subunit of the mediator complex termed
PRIC295.
In the course of executing their physiological roles,
PPARs are both regulated by and intersect with diverse
signaling pathways. Three review articles touch on three of
these many types of interactions. Charoensuksai and Xu
reviewtheeﬀectsofcircadiansignalingontheexpressionand
activitiesofPPARs,Morenoetal.summarizetheinteractions
between nutrient signaling and PPARs, whereas Takada
et al. expand on the interaction of PPARγ with downstream
eﬀectorsofcytokineandWntsignalinginmesenchymalstem
cells.2 PPAR Research
While this volume is a solid start, it did not go the full
distance and many of the molecular bases of PPAR function
remain to be reviewed. Some topics, such as the structure-
function relationships of PPARs or their posttranslational
regulation won no coverage in this issue. Among the
touched upon topics, some additional reviews are crucial for
rounding out the coverage, such as target genes of PPARβ/δ
or additional signaling crosstalk of PPARs. And so, it would
be great to see a fresh team of guest editors pick the topic up
where we left oﬀ and cover the next expanse of this literature
gap.
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